Free Trial

Zevra Therapeutics (ZVRA) SEC Filings & 10K Form

Zevra Therapeutics logo
$12.01 -0.12 (-0.99%)
Closing price 04:00 PM Eastern
Extended Trading
$11.80 -0.21 (-1.75%)
As of 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Zevra Therapeutics SEC Filings

DateFilerForm TypeView
06/26/2025
3:25 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
4:28 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:37 PM
Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:38 PM
Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:38 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:39 PM
FAVORITO TAMARA A (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:39 PM
Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:40 PM
DIXON WENDY L (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
8:41 PM
Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
4:21 PM
Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form PRRN14A
04/23/2025
4:29 PM
Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form DFAN14A
04/21/2025
6:02 AM
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form DEFC14A
04/21/2025
6:17 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form DEFA14A
04/10/2025
4:14 PM
Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form PREC14A
04/07/2025
3:31 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form DEFA14A
04/07/2025
7:04 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
7:05 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
4:28 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form DEFA14A
03/27/2025
7:30 PM
Quartel Adrian W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2025
7:31 PM
Quartel Adrian W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
5:06 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2025
4:23 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:38 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:54 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:55 PM
Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:55 PM
Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
4:57 PM
Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:38 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
8:32 AM
Adage Capital Management, L.P. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SCHEDULE 13G
02/10/2025
4:37 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
4:19 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:20 PM
Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:22 PM
Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:23 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:24 PM
Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:28 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SCHEDULE 13G/A
11/04/2024
1:15 PM
VANGUARD GROUP INC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SC 13G/A
10/16/2024
3:46 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Crypto bros: Meet your replacement (Ad)

Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.

Now he’s revealing the entire thing… FREE.
08/09/2024
3:54 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ZVRA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners